Tibion and Stanford University sign collaborative agreement

As a result of the agreement, a team of Stanford graduate students will be working to extend Tibion’s technology platform to additional medical applications. The work will serve as a foundation for future development activities to address mobility impairment across a wide range of acute and chronic indications.

The Stanford team will build on the bionic technology platform provided by Tibion to achieve enhanced mobility for patients suffering from neuromuscular or musculoskeletal pathologies.

Tom Andriacchi, chairman of biomechanical engineering group and professor of orthopaedic surgery at Stanford, said: “The industry collaboration with Tibion has generated much excitement because of the technology’s capacity to improve the quality of life for many people.”